
Syneos Health SYNH
Quartalsbericht 2023-Q1
hinzugefügt 10.05.2023
Syneos Health Betriebsaufwand 2011-2026 | SYNH
Betriebsaufwand Jährlich Syneos Health
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 4.12 B | 689 M | 680 M | 463 M | 232 M | 213 M | 200 M | 176 M | 188 M | 159 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 4.12 B | 159 M | 712 M |
Betriebsaufwand anderer Aktien in der Diagnostik & Forschung
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
1.99 B | $ 115.35 | -2.33 % | $ 35.1 B | ||
|
Anixa Biosciences
ANIX
|
9.98 M | $ 2.81 | -2.7 % | $ 91.2 K | ||
|
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M | ||
|
Brainsway Ltd.
BWAY
|
29.2 M | $ 12.28 | -2.69 % | $ 99.4 M | ||
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M | ||
|
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M | ||
|
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | ||
|
Burning Rock Biotech Limited
BNR
|
726 M | $ 22.48 | -1.58 % | $ 234 M | ||
|
Bioventus
BVS
|
217 M | $ 8.45 | -7.14 % | $ 563 M | ||
|
Celcuity
CELC
|
113 M | $ 114.85 | -0.34 % | $ 4.53 B | ||
|
Castle Biosciences
CSTL
|
59.5 M | $ 27.23 | -2.44 % | $ 756 M | ||
|
Charles River Laboratories International
CRL
|
607 M | $ 175.23 | -3.37 % | $ 8.69 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M | ||
|
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | ||
|
Co-Diagnostics
CODX
|
45.3 M | - | - | $ 79.8 M | ||
|
Fulgent Genetics
FLGT
|
181 M | $ 14.59 | 2.41 % | $ 441 M | ||
|
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | ||
|
Biodesix
BDSX
|
106 M | $ 18.61 | 17.37 % | $ 2.41 B | ||
|
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | ||
|
Illumina
ILMN
|
3.69 B | $ 124.76 | -2.71 % | $ 19.8 B | ||
|
IQVIA Holdings
IQV
|
2.94 B | $ 175.33 | -1.8 % | $ 30.1 B | ||
|
BioNano Genomics
BNGO
|
41.3 M | $ 1.11 | -1.36 % | $ 1.41 M | ||
|
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | ||
|
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 199.8 | -2.07 % | $ 22.2 B | ||
|
Danaher Corporation
DHR
|
6.71 B | $ 195.75 | -2.99 % | $ 140 B | ||
|
IDEXX Laboratories
IDXX
|
1.3 B | $ 607.19 | -1.9 % | $ 48.8 B | ||
|
Exact Sciences Corporation
EXAS
|
2.47 B | $ 103.5 | 0.17 % | $ 19.5 B | ||
|
DarioHealth Corp.
DRIO
|
62.2 M | $ 9.69 | -3.0 % | $ 275 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 269.52 | -2.34 % | $ 22.4 B | ||
|
DexCom
DXCM
|
1.89 B | $ 68.5 | -3.1 % | $ 26.7 B | ||
|
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B | ||
|
ICON Public Limited Company
ICLR
|
408 M | $ 107.08 | -3.19 % | $ 8.83 B | ||
|
Lantheus Holdings
LNTH
|
123 M | $ 72.86 | -4.53 % | $ 4.92 B | ||
|
CareDx, Inc
CDNA
|
411 M | $ 17.91 | -4.48 % | $ 954 M | ||
|
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | ||
|
Mettler-Toledo International
MTD
|
1.01 B | $ 1 215.85 | -3.66 % | $ 25.1 B | ||
|
Myriad Genetics
MYGN
|
964 M | $ 5.15 | 0.29 % | $ 477 M | ||
|
NeoGenomics
NEO
|
430 M | $ 8.92 | -2.3 % | $ 1.14 B | ||
|
National Research Corporation
NRC
|
38.5 M | $ 14.48 | 3.13 % | $ 324 M | ||
|
Guardant Health
GH
|
226 M | $ 91.56 | -1.1 % | $ 11.5 B | ||
|
Natera
NTRA
|
258 M | $ 196.94 | -0.1 % | $ 19.4 B | ||
|
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | ||
|
OPKO Health
OPK
|
217 M | $ 1.18 | 0.43 % | $ 819 M | ||
|
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K |